Literature DB >> 18499669

Fibronectin-tissue transglutaminase matrix rescues RGD-impaired cell adhesion through syndecan-4 and beta1 integrin co-signaling.

Dilek Telci1, Zhuo Wang, Xiaoling Li, Elisabetta A M Verderio, Martin J Humphries, Manuela Baccarini, Huveyda Basaga, Martin Griffin.   

Abstract

Heterotropic association of tissue transglutaminase (TG2) with extracellular matrix-associated fibronectin (FN) can restore the adhesion of fibroblasts when the integrin-mediated direct binding to FN is impaired using RGD-containing peptide. We demonstrate that the compensatory effect of the TG-FN complex in the presence of RGD-containing peptides is mediated by TG2 binding to the heparan sulfate chains of the syndecan-4 cell surface receptor. This binding mediates activation of protein kinase Calpha (PKCalpha) and its subsequent interaction with beta(1) integrin since disruption of PKCalpha binding to beta(1) integrins with a cell-permeant competitive peptide inhibits cell adhesion and the associated actin stress fiber formation. Cell signaling by this process leads to the activation of focal adhesion kinase and ERK1/2 mitogen-activated protein kinases. Fibroblasts deficient in Raf-1 do not respond fully to the TG-FN complex unless either the full-length kinase competent Raf-1 or the kinase-inactive domain of Raf-1 is reintroduced, indicating the involvement of the Raf-1 protein in the signaling mechanism. We propose a model for a novel RGD-independent cell adhesion process that could be important during tissue injury and/or remodeling whereby TG-FN binding to syndecan-4 activates PKCalpha leading to its association with beta(1) integrin, reinforcement of actin-stress fiber organization, and MAPK pathway activation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18499669      PMCID: PMC3258940          DOI: 10.1074/jbc.M801763200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Tissue transglutaminase, coagulation factor XIII, and the pro-polypeptide of von Willebrand factor are all ligands for the integrins alpha 9beta 1 and alpha 4beta 1.

Authors:  H Takahashi; T Isobe; S Horibe; J Takagi; Y Yokosaki; D Sheppard; Y Saito
Journal:  J Biol Chem       Date:  2000-08-04       Impact factor: 5.157

Review 2.  Syndecans and cell adhesion.

Authors:  J R Couchman; L Chen; A Woods
Journal:  Int Rev Cytol       Date:  2001

3.  Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion.

Authors:  A M Belkin; S S Akimov; L S Zaritskaya; B I Ratnikov; E I Deryugina; A Y Strongin
Journal:  J Biol Chem       Date:  2001-03-02       Impact factor: 5.157

4.  Syndecan-4 binding to the high affinity heparin-binding domain of fibronectin drives focal adhesion formation in fibroblasts.

Authors:  A Woods; R L Longley; S Tumova; J R Couchman
Journal:  Arch Biochem Biophys       Date:  2000-02-01       Impact factor: 4.013

5.  Identification of a novel heparin-binding site in the alternatively spliced IIICS region of fibronectin: roles of integrins and proteoglycans in cell adhesion to fibronectin splice variants.

Authors:  Z Mostafavi-Pour; J A Askari; J D Whittard; M J Humphries
Journal:  Matrix Biol       Date:  2001-02       Impact factor: 11.583

Review 6.  Focal adhesion kinase: in command and control of cell motility.

Authors:  Satyajit K Mitra; Daniel A Hanson; David D Schlaepfer
Journal:  Nat Rev Mol Cell Biol       Date:  2005-01       Impact factor: 94.444

7.  Analysis of tissue transglutaminase function in the migration of Swiss 3T3 fibroblasts: the active-state conformation of the enzyme does not affect cell motility but is important for its secretion.

Authors:  Zita Balklava; Elisabetta Verderio; Russell Collighan; Stephane Gross; Julian Adams; Martin Griffin
Journal:  J Biol Chem       Date:  2002-02-26       Impact factor: 5.157

8.  Ezrin is a downstream effector of trafficking PKC-integrin complexes involved in the control of cell motility.

Authors:  T Ng; M Parsons; W E Hughes; J Monypenny; D Zicha; A Gautreau; M Arpin; S Gschmeissner; P J Verveer; P I Bastiaens; P J Parker
Journal:  EMBO J       Date:  2001-06-01       Impact factor: 11.598

9.  Site-directed perturbation of protein kinase C- integrin interaction blocks carcinoma cell chemotaxis.

Authors:  Maddy Parsons; Melanie D Keppler; Adam Kline; Anthea Messent; Martin J Humphries; Ruth Gilchrist; Ian R Hart; Corinne Quittau-Prevostel; William E Hughes; Peter J Parker; Tony Ng
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

10.  Syndecan-4 modulates focal adhesion kinase phosphorylation.

Authors:  Sarah A Wilcox-Adelman; Fabienne Denhez; Paul F Goetinck
Journal:  J Biol Chem       Date:  2002-06-26       Impact factor: 5.157

View more
  49 in total

1.  RGD-independent cell adhesion via a tissue transglutaminase-fibronectin matrix promotes fibronectin fibril deposition and requires syndecan-4/2 α5β1 integrin co-signaling.

Authors:  Zhuo Wang; Russell J Collighan; Stephane R Gross; Erik H J Danen; Gertraud Orend; Dilek Telci; Martin Griffin
Journal:  J Biol Chem       Date:  2010-10-07       Impact factor: 5.157

2.  Celiac disease patient IgA antibodies induce endothelial adhesion and cell polarization defects via extracellular transglutaminase 2.

Authors:  Cristina Antonella Nadalutti; Ilma Rita Korponay-Szabo; Katri Kaukinen; Martin Griffin; Markku Mäki; Katri Lindfors
Journal:  Cell Mol Life Sci       Date:  2013-08-28       Impact factor: 9.261

3.  Transglutaminase 2 modulation of NF-κB signaling in astrocytes is independent of its ability to mediate astrocytic viability in ischemic injury.

Authors:  Julianne Feola; Alan Barton; Abdullah Akbar; Jeffrey Keillor; Gail V W Johnson
Journal:  Brain Res       Date:  2017-05-15       Impact factor: 3.252

Review 4.  Cellular functions of tissue transglutaminase.

Authors:  Maria V Nurminskaya; Alexey M Belkin
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

Review 5.  Transglutaminase regulation of cell function.

Authors:  Richard L Eckert; Mari T Kaartinen; Maria Nurminskaya; Alexey M Belkin; Gozde Colak; Gail V W Johnson; Kapil Mehta
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

6.  Syndecan-4 knockout leads to reduced extracellular transglutaminase-2 and protects against tubulointerstitial fibrosis.

Authors:  Alessandra Scarpellini; Linghong Huang; Izhar Burhan; Nina Schroeder; Muriel Funck; Timothy S Johnson; Elisabetta A M Verderio
Journal:  J Am Soc Nephrol       Date:  2013-12-19       Impact factor: 10.121

7.  Tissue Tranglutaminase Regulates Interactions between Ovarian Cancer Stem Cells and the Tumor Niche.

Authors:  Salvatore Condello; Livia Sima; Cristina Ivan; Horacio Cardenas; Gary Schiltz; Rama K Mishra; Daniela Matei
Journal:  Cancer Res       Date:  2018-03-06       Impact factor: 12.701

8.  Transglutaminase 2 and its role in pulmonary fibrosis.

Authors:  Keith C Olsen; Ramil E Sapinoro; R M Kottmann; Ajit A Kulkarni; Siiri E Iismaa; Gail V W Johnson; Thomas H Thatcher; Richard P Phipps; Patricia J Sime
Journal:  Am J Respir Crit Care Med       Date:  2011-06-23       Impact factor: 21.405

Review 9.  Transglutaminase 2: Friend or foe? The discordant role in neurons and astrocytes.

Authors:  Breandan R Quinn; Laura Yunes-Medina; Gail V W Johnson
Journal:  J Neurosci Res       Date:  2018-03-23       Impact factor: 4.164

10.  Transglutaminase-2 in cell adhesion: all roads lead to paxillin?

Authors:  Evelyn Png; Louis Tong
Journal:  Cell Adh Migr       Date:  2013-09-12       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.